Crinò, L

A better therapeutic profile for the combination of mitomycin-C, ifosfamide and cisplatin (MIC) in advanced non-small-cell lung cancer: a useful dose-schedule modification. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jul 1997 - 709-11 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial

0923-7534

10.1023/a:1008277604261 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Cisplatin--administration & dosage
Drug Administration Schedule
Female
Humans
Ifosfamide--administration & dosage
Lung Neoplasms--drug therapy
Male
Middle Aged
Mitomycin--administration & dosage